Lupus Clinical Trials in New York

Showing 121-140 of 142 trials

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

NCT02391259

This is a multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study in which approximately 56 subjects with SLE will be enrolled in 7 dosing cohorts

Systemic Lupus Erythematosus

Amgen57 participantsStarted Nov 2006

Anniston, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +10 more locations

COMPLETEDPHASE3< 1 mile

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

NCT01430754

The purpose of this study is to evaluate the maintenance effect and safety of 20 mg tasimelteon versus placebo in subjects suffering from Non-24-Hour Sleep-Wake Disorder.

Non-24-Hour Sleep-Wake Disorder

Vanda Pharmaceuticals20 participantsStarted Sep 2011

Phoenix, Arizona, United States • Orange, California, United States • Palo Alto, California, United States +19 more locations

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Lupus Trials in Other Cities

World Trade Center (WTC) CHEST

Study of Epratuzumab in Systemic Lupus Erythematosus

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Study of Epratuzumab in Systemic Lupus Erythematosus

A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects

Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil

Functional MRI in Lupus Nephritis

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

The Role of ITGAM in Systemic Lupus Erythematosus

Etanercept for the Treatment of Lupus Nephritis

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Other Conditions in New York